Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. External Web Site Icon | Specific PHGKB|Cancer|PHGKB

Specific PHGKB|Cancer|PHGKB

Colorectal Cancer Genomics

- Cancer PHGKB -

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

---

• Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.  
  Published 2017 (American Society for Clinical Pathology (ASCP)) (College of American Pathologists (CAP)) (American Society of Clinical Oncology (ASCO)) (Association for Molecular Pathology )
• Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.  
  Published 2017 (American Society for Clinical Pathology (ASCP)) (College of American Pathologists (CAP)) (Association for Molecular Pathology (AMP)) (Association for Molecular Pathology (AMP))
• Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.  
  Published 2016 (American College of Medical Genetics and Genomics (ACMG))
• Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer.  
  Published 2014 (U.S. Multi-Society Task Force on Colorectal Cancer)
• Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients.  
  Published 2015 (Japanese Society of Medical Oncology)

more